Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer.
Markowski MC, Ren Y, Tierney M, Royce TJ, Yamashita R, Croucher D, Huang HC, Todorovic T, Chen E, Showalter TN, Carducci MA, Chen YH, Liu G, Parker CTA, Esteva A, Feng FY, Attard G, Sweeney CJ. Markowski MC, et al. Among authors: royce tj. Eur Urol Oncol. 2024 Dec 10:S2588-9311(24)00271-2. doi: 10.1016/j.euo.2024.11.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39665917
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.
Wang JH, Deek MP, Mendes AA, Song Y, Shetty A, Bazyar S, Van der Eecken K, Chen E, Showalter TN, Royce TJ, Todorovic T, Huang HC, Houck SA, Yamashita R, Kiess AP, Song DY, Lotan T, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N, Berlin A, Onal C, Esteva A, Feng FY, Tran PT, Sutera P, Ost P. Wang JH, et al. Among authors: royce tj. Radiother Oncol. 2024 Nov 6;202:110618. doi: 10.1016/j.radonc.2024.110618. Online ahead of print. Radiother Oncol. 2024. PMID: 39510141 Free article.
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials.
Spratt DE, Liu VYT, Jia AY, Royce TJ, Sandler HM, Pugh SL, Tran PT, Feng FY. Spratt DE, et al. Among authors: royce tj. Eur Urol. 2024 Oct;86(4):369-371. doi: 10.1016/j.eururo.2024.06.019. Epub 2024 Jul 17. Eur Urol. 2024. PMID: 39025748 Free PMC article. No abstract available.
121 results